Welcome: Guest

log in

Pharma & Biotech Market Research

In this section you will find information products, including market research reports, on the following sector: Pharma & Biotech

Stay up-to-date with new products added to this category
Title Date Price
OncoGenex Pharmaceuticals Inc.-Detailed Product Pipeline
Sep 2009 £460
Oncolin Therapeutics, Inc.-Detailed Product Pipeline
Sep 2009 £460
Osteologix, Inc.-Detailed Product Pipeline
Sep 2009 £460
Oncothyreon, Inc.-Detailed Product Pipeline
Sep 2009 £460
Onyx Pharmaceuticals Inc-Detailed Product Pipeline
Sep 2009 £460
Nymox Pharmaceutical Corporation-Detailed Product Pipeline
Sep 2009 £460
Nycomed International Management GmbH-Company Report
Sep 2009 £460
Nxstage Medical, Inc.-Deals & Alliances Report
Sep 2009 £370
Nutrition 21 Inc-Detailed Product Pipeline
Sep 2009 £460
Ochoa Laboratories Limited-Company Report
Sep 2009 £460
Oculus Innovative Sciences Inc-Detailed Product Pipeline
Sep 2009 £460
Optimer Pharmaceuticals, Inc.-Detailed Product Pipeline
Sep 2009 £460
Opko Health, Inc.-Detailed Product Pipeline
Sep 2009 £460
OSI Pharmaceuticals Inc-Detailed Product Pipeline
Sep 2009 £460
Ore Pharmaceuticals Inc.-Detailed Product Pipeline
Sep 2009 £460
Osiris Therapeutics Inc-Detailed Product Pipeline
Sep 2009 £460
Oxygen Biotherapeutics, Inc.-Detailed Product Pipeline
Sep 2009 £460
OXIS International Inc-Detailed Product Pipeline
Sep 2009 £460
Oscient Pharmaceuticals Corp-Detailed Product Pipeline
Sep 2009 £460
ONI BioPharma, Inc.-Detailed Product Pipeline
Sep 2009 £460
Opexa Therapeutics Inc-Detailed Product Pipeline
Sep 2009 £460
Oramed Pharmaceuticals Inc-Detailed Product Pipeline
Sep 2009 £460
Orexigen Therapeutics, Inc.-Detailed Product Pipeline
Sep 2009 £460
Orbus Pharma Inc-Company Report
Sep 2009 £460
Northwest Biotherapeutics Inc-Detailed Product Pipeline
Sep 2009 £460
Novartis AG-Detailed Product Pipeline
Sep 2009 £460
NeurogesX, Inc.-Detailed Product Pipeline
Sep 2009 £460
NexMed Inc-Detailed Product Pipeline
Sep 2009 £460
Neuro-Hitech Pharmaceuticals Inc-Detailed Product Pipeline
Sep 2009 £460
Nile Therapeutics, Inc-Detailed Product Pipeline
Sep 2009 £460
Nektar Therapeutics-Detailed Product Pipeline
Sep 2009 £460
NeoPharm Inc-Detailed Product Pipeline
Sep 2009 £460
Neurogenesis Inc-Detailed Product Pipeline
Sep 2009 £460
NovaBay Pharmaceuticals, Inc.-Detailed Product Pipeline
Sep 2009 £460
Neurocrine Biosciences Inc-Detailed Product Pipeline
Sep 2009 £460
Natrapharm Inc.-Company Report
Sep 2009 £460
Nucryst Pharmaceuticals Corp-Detailed Product Pipeline
Sep 2009 £460
NanoViricides, Inc.-Detailed Product Pipeline
Sep 2009 £460
Novus Pharmaceuticals Ltd.-Company Report
Sep 2009 £460
Novavax Inc-Detailed Product Pipeline
Sep 2009 £460
NuRx Pharmaceuticals, Inc-Detailed Product Pipeline
Sep 2009 £460
Novadel Pharma Inc-Detailed Product Pipeline
Sep 2009 £460
Novelos Therapeutics Inc-Detailed Product Pipeline
Sep 2009 £460
Neurobiological Technologies Inc-Detailed Product Pipeline
Sep 2009 £460
Neurologix Inc-Detailed Product Pipeline
Sep 2009 £460
Nutra Pharma Corp-Detailed Product Pipeline
Sep 2009 £460
NovImmune SA-Company Report
Sep 2009 £460
Neurogen Corporation-Detailed Product Pipeline
Sep 2009 £460
NPS Pharmaceuticals Inc-Detailed Product Pipeline
Sep 2009 £460
OXiGENE INC-Detailed Product Pipeline
Sep 2009 £460
Panacos Pharmaceuticals Inc-Detailed Product Pipeline
Sep 2009 £460
Regeneron Pharmaceuticals Inc-Detailed Product Pipeline
Sep 2009 £460
Ardea Biosciences, Inc.-Detailed Product Pipeline
Sep 2009 £460
Repligen Corporation-Detailed Product Pipeline
Sep 2009 £460
RegeneRx Biopharmaceuticals Inc-Detailed Product Pipeline
Sep 2009 £460
Rigel Pharmaceuticals Inc-Detailed Product Pipeline
Sep 2009 £460
QLT Inc-Detailed Product Pipeline
Sep 2009 £460
Questcor Pharmaceuticals Inc-Detailed Product Pipeline
Sep 2009 £460
Pain Therapeutics Inc-Detailed Product Pipeline
Sep 2009 £460
Provectus Pharmaceuticals Inc-Detailed Product Pipeline
Sep 2009 £460
PolyMedix Inc-Detailed Product Pipeline
Sep 2009 £460
The Quigley Corporation-Detailed Product Pipeline
Sep 2009 £460
Rexahn Pharmaceuticals Inc-Detailed Product Pipeline
Sep 2009 £460
Rockwell Medical Technologies Inc-Detailed Product Pipeline
Sep 2009 £460
Sangamo BioSciences Inc-Detailed Product Pipeline
Sep 2009 £460
Seattle Genetics Inc-Detailed Product Pipeline
Sep 2009 £460
Schering-Plough Corp-Detailed Product Pipeline
Sep 2009 £460
Shire plc-Detailed Product Pipeline
Sep 2009 £460
Sepracor Inc-Detailed Product Pipeline
Sep 2009 £460
Sinofresh Healthcare Inc.-Detailed Product Pipeline
Sep 2009 £460
Repros Therapeutics Inc-Detailed Product Pipeline
Sep 2009 £460
SciClone Pharmaceuticals Inc-Detailed Product Pipeline
Sep 2009 £460
Raptor Pharmaceuticals Corp.-Detailed Product Pipeline
Sep 2009 £460
Sucampo Pharmaceuticals, Inc.-Detailed Product Pipeline
Sep 2009 £460
Palatin Technologies Inc-Detailed Product Pipeline
Sep 2009 £460
Proteo Inc-Detailed Product Pipeline
Sep 2009 £460
Progenics Pharmaceuticals Inc-Detailed Product Pipeline
Sep 2009 £460
Procter & Gamble Company-Detailed Product Pipeline
Sep 2009 £460
PanGenex Corporation-Detailed Product Pipeline
Sep 2009 £460
PacificHealth Laboratories Inc-Detailed Product Pipeline
Sep 2009 £460
Protalix Biotherapeutics, Inc.-Detailed Product Pipeline
Sep 2009 £460
Pfizer Inc-Detailed Product Pipeline
Sep 2009 £460
PDL BioPharma Inc-Detailed Product Pipeline
Sep 2009 £460
Pharmos Corporation-Detailed Product Pipeline
Sep 2009 £460
Poniard Pharmaceuticals Inc-Detailed Product Pipeline
Sep 2009 £460
Pharmacyclics Inc-Detailed Product Pipeline
Sep 2009 £460
Peplin Ltd-Detailed Product Pipeline
Sep 2009 £460
PharmAthene, Inc.-Detailed Product Pipeline
Sep 2009 £460
POZEN Inc-Detailed Product Pipeline
Sep 2009 £460
Protalex Inc-Detailed Product Pipeline
Sep 2009 £460
Par Pharmaceutical Companies Inc-Detailed Product Pipeline
Sep 2009 £460
Pluristem Therapeutics, Inc.-Detailed Product Pipeline
Sep 2009 £460
Psivida Ltd-Detailed Product Pipeline
Sep 2009 £460
Pro-Pharmaceuticals Inc-Detailed Product Pipeline
Sep 2009 £460
Proteonomix, Inc.-Detailed Product Pipeline
Sep 2009 £460
Polydex Pharmaceuticals Ltd-Detailed Product Pipeline
Sep 2009 £460
Penwest Pharmaceuticals Co-Detailed Product Pipeline
Sep 2009 £460
Peregrine Pharmaceuticals Inc-Detailed Product Pipeline
Sep 2009 £460
Perrigo Company-Detailed Product Pipeline
Sep 2009 £460
Sanguine Corp-Detailed Product Pipeline
Sep 2009 £460

Industry Events